← All trials
NCT05874310
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2023
- Primary completion
- Oct 31, 2023
- Completion date
- Nov 1, 2027
- First posted
- May 24, 2023
- Last posted
- May 24, 2023
- Enrollment
- 18
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Frontera TherapeuticsLead sponsor
- Fudan UniversityCollaborator
- Fudan UniversityOverall official - principal investigator
- Henan Provincal People's HospitalCollaborator
- Chinese Academy of Medical SciencesCollaborator
- Chinese Academy of Medical SciencesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.